DeutschNewstral
Article
jdsupra.com on 2023-11-02 01:06
FDA: New Draft Guidance on Communication of Unapproved Uses of Approved or Cleared Medical Products
Related news
- FDA Revises Guidance Concerning Scientific Communications to HCPs about Unapproved Uses of Approved/Cleared Medical Productsjdsupra.com
- FDA Issues Draft Guidance on Providing Health Care Providers With Scientific Information on Unapproved Uses of Approved/Cleared Medical Productsjdsupra.com
- FDA broadens scope on communication about unapproved uses to HCPsjdsupra.com
- FDA Issues Revised Draft Guidance on “Scientific Information on Unapproved Uses Communications”jdsupra.com
- FDA Cracks Down on Unapproved Eye Productsjdsupra.com
- FDA Releases Final Guidance: Transition of Previously Approved Drugs to Being "Deemed Licensed" Biologicsjdsupra.com
FDA cracks down on unapproved ear dropswkrg.com
FDA pulls unapproved prescription ear dropsKnoxville News Sentinel
FDA Cracks Down On Unapproved Ear DropsWBNS-10TV- FDA Reinstates Unapproved New Drug Initiativejdsupra.com
- FDA Releases Naming Guidancejdsupra.com
- UFDA issues warning to pet companies for selling unapproved antibioticsupi.com
- DFDA approved salmondanbyink.bangordailynews.com
- FDA to Prioritize Enforcement Actions Against Unapproved Homeopathic Drugsjdsupra.com
- TEditorial: FDA must get rid of unapproved herbal productsthechronicle.com.gh
- Guidance from FDA Clarifies a Key Issue for Industry: Non-Promotional Presentations About Unapproved Uses of Medical Products Can Be Produced by the Products’ Sponsors Without Violating Off-Label Rulesjdsupra.com
- FDA Releases Public Inventory of Unapproved Food Additivesjdsupra.com
- FDA Will Hold Hearing on Communications Regarding Unapproved Usesjdsupra.com
- FDA and FTC Warn Against Making Unapproved COVID-19 Claimsjdsupra.com